Abstract:Improved methods for early cancer detection arising from Barrett’s oesophagus (BE) are still needed. Imaging molecular expression patterns in BE patients can target neoplasia. We demonstrate a multiplexed fluorescence imaging approach to detect premalignant lesions with two fluorescently labeled heptapeptides specific for EGFR and ErbB2. Twenty-two BE patients underwent endoscopic imaging with a multimodal scanning fiber endoscope (mmSFE). In this pilot study, 92% of neoplastic lesions could be imaged by comparison with pathology, with only 11% false positives. This first-in-human study demonstrates feasibility to concurrently detect multiple targets in vivo and potential for early detection of cancers that are molecularly heterogeneous. ### Background Oesophageal adenocarcinoma (EAC) is a deadly disease that has increased dramatically in incidence over the past several decades.1 2 Endoscopic screening with white light illumination and random biopsy is limited by sampling error.3 Dysplasia often presents with flat architecture and patchy distribution.4 EGFR and ErbB2 are transmembrane tyrosine kinase receptors that stimulate epithelial cell growth, proliferation and differentiation.5 Overexpression of these targets reflects a higher risk for cancer progression.6–8 Multiplexed imaging methods take advantage of the broad spectrum of light over the visible and near-infrared (NIR) regimen. We aim to demonstrate clinical feasibility to visualise EGFR and ErbB2 expression simultaneously in vivo to detect Barrett’s neoplasia. ### Methods Consecutive patients referred for either evaluation or therapy of Barrett’s neoplasia were recruited for the study (NCT03589443). An mmSFE was designed to collect multiplexed fluorescence images concurrently. Target/background (T/B) ratios were calculated for each fluorescence image. More details on the methods and the multiplexed imaging technology can be found in the online supplemental file. ### Supplementary data [gutjnl-2020-322945supp001.pdf] ### Results The peptide QRHKPRE specific for EGFR was labelled with Cy5 via a GGGSK linker, (figure 1A).9 KSPNPRF, specific for ErbB2, was labelled with IRDye800 via a GGGSC linker (figure 1B). …

Quantitative phase and polarisation endoscopy applied to detection of early oesophageal tumourigenesis

Quantitative phase imaging through an ultra-thin lensless fiber endoscope

Ultra-miniature dual-wavelength spatial frequency domain imaging for micro-endoscopy

Quantitative phase imaging of opaque specimens with flexible endoscopic microscopy

Multi-spectral video endoscopy system for the detection of cancerous tissue

Endomicroscopic Optical Coherence Tomography for Cellular Resolution Imaging of Gastrointestinal Tracts

Non-Invasive Discrimination of Colorectal Adenomas and Non-Neoplastic Polyps with Micro-Optical Coherence Tomography Imaging.

Emerging Fiber-Optic Endomicroscopy Technologies Towards Noninvasive Real-Time Visualization of Histology in Situ

Multispectral light scattering endoscopic imaging of esophageal precancer

Next-generation endoscopic probe for detection of esophageal dysplasia using combined OCT and angle-resolved low-coherence interferometry

Multimodal endoscope can quantify wide-field fluorescence detection of Barrett's neoplasia.

Ex vivo optical coherence tomography combined with near infrared targeted fluorescence: towards in-vivo esophageal cancer detection

Surgical polarimetric endoscopy for the detection of laryngeal cancer

Quantitative phase imaging endoscopy with a metalens

Flexible $3\times3$ Mueller Matrix Endoscope Prototype for Cancer Detection

Label-free tissue scanner for colorectal cancer screening

Quantitative Multiphoton Imaging of Cell Metabolism, Stromal Fibers, and Keratinization Enables Label-Free Discrimination of Esophageal Squamous Cell Carcinoma

Reconstruction of optical vector-fields with applications in endoscopic imaging

Multiplexed Endoscopic Imaging of Barrett’s Neoplasia Using Targeted Fluorescent Heptapeptides in a Phase 1 Proof-of-concept Study